«The phi test helps physicians distinguish prostate cancer from benign conditions by utilizing three different PSA markers (PSA, freePSA and p2PSA) as part of a sophisticated algorithm to more
reliably determine the probability of cancer in patients with elevated PSA
levels,» said Kevin Slawin, MD, director, Vanguard Urologic Institute
at Memorial Hermann Medical Group, clinical professor of Urology
at Baylor College of Medicine and director of Urology, Memorial Hermann Hospital ‐ Texas Medical Center, who
performed some of the key research that led to the development of the phi test and who also began using the test in February.
A functional connectivity approach
at the subregional
level may therefore yield novel insights into GAD.To determine whether distinct connectivity patterns can be
reliably identified for the basolateral (BLA) and centromedial (CMA) subregions of the human amygdala, and to examine subregional connectivity patterns and potential compensatory amygdalar connectivity in GAD.Cross - sectional study.Academic medical center.Two cohorts of healthy control subjects (consisting of 17 and 31 subjects) and 16 patients with GAD.Functional connectivity with cytoarchitectonically determined BLA and CMA regions of interest, measured during functional magnetic resonance imaging
performed while subjects were resting quietly in the scanner.